Skip to the answer

Mesna Uses, Dosage, Side Effects and Interactions

Brand name
Mesnex

Mesnex was approved by the FDA in December 1988. An FDA-approved generic with the same active ingredient is listed.

Mesna is a cytoprotective (bladder-protecting) agent used alongside ifosfamide chemotherapy to reduce the risk of hemorrhagic cystitis (serious bladder bleeding).

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About MesnaType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Mesna in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Mesna (Mesnex) is a bladder-protecting medicine given with ifosfamide chemotherapy. It binds and neutralizes ifosfamide’s toxic byproducts in the urine to help prevent hemorrhagic cystitis (serious bladder bleeding), and it is a standard companion to ifosfamide, not a cancer treatment, on the U.S. market since about 1987 with FDA-approved generics listed. Most people tolerate it well, and its usual effects (nausea, tiredness, headache) are hard to tell apart from the chemotherapy itself. Watch for a serious allergic or skin reaction (trouble breathing, swelling, or a blistering, peeling rash), which can strike at the first dose or months later and needs emergency care.

Key Takeaways From the HelloPharmacist Team

  • Expect mesna with each ifosfamide dose, all by IV (into a vein) or IV then tablets at set hours, every ifosfamide day.
  • Call your care team if you vomit within two hours of a mesna tablet; you may need a repeat dose or IV mesna.
  • Report pink or red urine promptly; mesna lowers ifosfamide’s bladder risk but does not stop bleeding from other causes, like low platelets.
  • Tell any lab you are on mesna, since it can falsely skew urine ketone, urine vitamin C and CPK (muscle enzyme) blood tests.

How we write and review this content: our editorial policy

Mesna by the Numbers

Strengths
2
across 2 forms
Makers and packagers
8
Earliest FDA record
1987
Rank by Medicaid prescriptions
#1,356 of 1,682 drugs
More prescriptions than 19% of the 1,682 drugs we measure
848 prescriptions, Q1–Q4 2025
Other forms and routes

Patient Information Guide for Mesna

What It’s Used For

Mesna is a cytoprotective (bladder-protecting) agent used specifically to prevent a serious complication of ifosfamide chemotherapy.

  • Ifosfamide-induced hemorrhagic cystitis (bladder bleeding): Both Mesna injection and Mesna/Mesnex tablets are approved to reduce the risk of this condition, in which toxic breakdown products of ifosfamide damage the bladder lining and cause bleeding.
  • Limitation: Mesna is not approved to prevent or treat blood in the urine caused by other conditions, such as thrombocytopenia (low platelet counts) or other diseases.

How It Works

Ifosfamide is broken down in the body into harmful byproducts — particularly acrolein and 4-hydroxy-ifosfamide — that end up in the urine and attack the lining of the bladder. Mesna works by chemically binding to these toxic metabolites in the urinary tract, converting them into harmless compounds before they can damage bladder tissue. It essentially acts as a targeted chemical neutralizer, protecting only the bladder without interfering with ifosfamide's cancer-fighting activity elsewhere in the body.

Drug Class

Drug Class

  • Cytoprotective Agent

From Mesna’s FDA label.

Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Cytoprotective Agent

The main drug class the FDA gives it. It is the class named on the drug’s label.

What It Does in the Body

Physiologic effect (PE)

None listed for Mesna in the FDA’s index.

From our Patient Information GuideIfosfamide is broken down in the body into harmful byproducts — particularly acrolein and 4-hydroxy-ifosfamide — that end up in the urine and attack the lining of the bladder. Read How Mesna Works

A change it makes in how the body works.

Drug Family

WHO ATC classification
  • Mucolytics
  • Detoxifying agents for antineoplastic treatment

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The drug class comes from Mesna’s FDA label. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification, from the U.S. National Library of Medicine’s RxClass. Reference only, not medical advice.

Dosage

Mesna is always given in close coordination with ifosfamide, and the schedule is repeated on every day that ifosfamide is administered. There are two approaches:

  • All-IV schedule: Mesna injection is given as three intravenous bolus injections — at the time of ifosfamide and at set intervals afterward (4 and 8 hours later).
  • IV-then-oral schedule: Mesna injection is given as one IV bolus at the time of ifosfamide, followed by oral mesna tablets at timed intervals (2 and 6 hours later). Food does not affect the urinary effectiveness of the oral tablets. If you vomit within two hours of an oral dose, contact your care team — you may need a repeat dose or a switch to IV.

If your ifosfamide dose is ever adjusted up or down, the mesna dose must be adjusted in proportion. Always follow the exact schedule your prescriber provides.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Mesna Injection

Protecting the bladder from bleeding caused by ifosfamide
People receiving ifosfamide · Intravenous schedule only Usual dose 240 mg/m2 of mesna injection at 0, 4 and 8 hours
  • Ifosfamide 1.2 g/m2 at 0 hours

Good to know

Repeat each day ifosfamide is given; keep the mesna to ifosfamide ratio if the ifosfamide dose changes

People receiving ifosfamide · Intravenous then oral schedule Usual dose 240 mg/m2 of mesna injection at 0 hours, then 480 mg/m2 of mesna tablets at 2 and 6 hours
  • Ifosfamide 1.2 g/m2 at 0 hours

Good to know

Efficacy and safety of this ratio not established for ifosfamide daily doses higher than 2 g/m2; repeat the dose or use IV mesna if vomiting within two hours of oral dose

IV means given into a vein (intravenous).

See the Full Dosing Instructions on DailyMed →

Mesna Taken by Mouth

Protecting the bladder from bleeding caused by ifosfamide
People receiving ifosfamide · Intravenous schedule only Usual dose 240 mg/m2 of Mesnex injection at 0, 4 and 8 hours
  • Ifosfamide 1.2 g/m2 at 0 hours

Good to know

Repeat each day ifosfamide is given; keep the ratio if the ifosfamide dose changes

People receiving ifosfamide · Intravenous then oral schedule Usual dose 240 mg/m2 of Mesnex injection at 0 hours, then 480 mg/m2 of Mesnex tablets at 2 and 6 hours
  • Ifosfamide 1.2 g/m2 at 0 hours

Good to know

Not established for ifosfamide daily doses higher than 2 g/m2; repeat the dose or use IV Mesnex if vomiting within two hours of oral dose

IV means given into a vein (intravenous).

See the Full Dosing Instructions on DailyMed →

Side Effects

Because mesna is given alongside ifosfamide chemotherapy, some side effects may come from ifosfamide rather than mesna alone. The most commonly reported effects include:

Common side effects

  • Nausea and vomiting
  • Fatigue and weakness
  • Constipation or diarrhea
  • Fever
  • Headache
  • Dizziness
  • Loss of appetite
  • Injection site reactions (with IV use)
  • Low blood cell counts (leukopenia, anemia, thrombocytopenia, granulocytopenia)
  • Somnolence (drowsiness)

When to get medical help

  • Signs of a severe allergic reaction (anaphylaxis): difficulty breathing, rapid heart rate, low blood pressure, swelling — seek emergency help immediately
  • Serious skin reactions such as widespread rash with blistering or peeling, mouth sores, or skin that looks burned — stop treatment and get medical help
  • Blood in your urine (hematuria) — notify your care team promptly
  • Signs of low blood pressure: lightheadedness, fainting, or feeling very weak
  • Unusual bleeding or bruising, or signs of low blood counts (fever, chills, extreme tiredness)

Seek immediate medical attention for signs of a severe allergic reaction (trouble breathing, chest tightness, swelling, sudden low blood pressure) or serious skin reactions such as widespread blistering or peeling — these require stopping mesna right away.

Warnings and Precautions

  • Severe allergic reactions (anaphylaxis): Mesna can cause life-threatening allergic reactions, including fever, low blood pressure, rapid heart rate, difficulty breathing, swelling, and organ effects. These can happen on the first dose or after months of use. Stop treatment and get emergency care immediately if these occur.
  • Serious skin reactions: Rare but dangerous skin conditions — including Stevens-Johnson syndrome and toxic epidermal necrolysis (widespread blistering and skin loss) — have been reported. Discontinue mesna and seek urgent care if a severe rash, blistering, or mouth sores develop.
  • Benzyl alcohol toxicity in newborns: Mesna injection contains benzyl alcohol, which has caused fatal reactions (including seizures, breathing failure, and cardiovascular collapse) in premature and low-birth-weight newborns. Mesna injection must not be used in these infants.
  • Lab test interference: Mesna can cause false-positive urine ketone tests, falsely low CPK (creatinine phosphokinase) blood test results, and false-positive ascorbic acid urine tests. Alert any lab that you are on mesna before testing.
  • History of thiol compound reactions: Mesna belongs to the thiol (sulfur-containing) drug class. Patients who have reacted to other thiol drugs may be at increased risk, though this is not fully established.

Interactions

No formal clinical drug interaction studies have been conducted with mesna. However, there are important considerations:

  • Urine ketone tests (nitroprusside-based dipsticks): Mesna can produce a false-positive result — tell your care team before any urine testing.
  • CPK (creatinine phosphokinase) blood tests using thiol-based reactivation: Mesna may cause falsely low CPK readings — inform your lab.
  • Ascorbic acid urine screening tests (Tillman's reagent-based): Mesna can produce false-positive results — alert your healthcare team.

Interactions Listed in the FDA-Approved Label

From the Mesna prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • What happensNo clinical drug interaction studies have been conducted with mesna injection.
Read the label’s full interactions text

7 DRUG INTERACTIONS No clinical drug interaction studies have been conducted with mesna injection.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Allergy to mesna or its ingredients: Do not use mesna if you are allergic to mesna or any component of the injection or tablets, including benzyl alcohol (in the injection).
  • History of reactions to thiol compounds (such as amifostine): Tell your doctor — there may be an increased risk of hypersensitivity.
  • Pregnancy: Ifosfamide, used alongside mesna, can harm a fetus. Females of reproductive potential must use effective contraception during treatment and for 6 months after the last dose. Pregnancy should be confirmed negative before starting treatment.
  • Breastfeeding: Do not breastfeed during treatment or for at least 1 week after the last dose of mesna or ifosfamide.
  • Males with reproductive-age partners: Use effective contraception during treatment and for 3 months after the last dose.
  • Premature newborns and low-birth-weight infants: Mesna injection must be avoided in these patients due to benzyl alcohol toxicity risk.
  • Older adults: Dose selection should be approached cautiously given the greater likelihood of reduced kidney, liver, or heart function in this age group.
  • Kidney or liver impairment: No formal studies have been done — your care team will monitor you closely.

Overdose

There is no known antidote for a mesna overdose. Taking too much can cause nausea, vomiting, diarrhea, and fever. Very high doses have also been associated with hypersensitivity reactions including low blood pressure, shortness of breath, rash, and flushing. If an overdose is suspected, contact a poison control center or emergency services immediately.

Half-Life and How Your Body Processes It

When taken orally, mesna is absorbed within 1.5 to 4 hours (free mesna) and reaches full absorption within 3 to 7 hours (total mesna), with oral bioavailability averaging about 58% for free mesna and 89% for total mesna. After IV administration, mesna distributes widely throughout body water. It is rapidly converted in the body to its main metabolite, mesna disulfide (dimesna). Both mesna and dimesna are eliminated through the urine — about one-third of an IV dose appears in the urine as each form within 24 hours. Mesna clears from the blood quickly, with a half-life of about 22 minutes; dimesna clears more slowly, with a half-life of about 70 minutes.

Storage

Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Mesna: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Mesna — the kind of thing our pharmacy team would talk through with you at the counter.

Why am I being given mesna — is it part of my cancer treatment?

Mesna itself doesn't treat cancer. Think of it as a protective companion to your ifosfamide chemotherapy. Ifosfamide breaks down into toxic byproducts that can damage your bladder and cause serious bleeding. Mesna is given at the same time — and again at set intervals afterward — to neutralize those harmful byproducts before they reach your bladder. It's all about keeping your bladder safe while your chemotherapy does its job.

What side effects should I expect, and which ones mean I need to call someone right away?

The most common effects — many of which may overlap with your ifosfamide — include nausea, vomiting, fatigue, constipation or diarrhea, fever, and headache. Most of these are manageable with support from your care team. However, call for help immediately if you develop trouble breathing, sudden swelling of the face or throat, a rapid drop in blood pressure, or widespread blistering or peeling of your skin. These could be signs of a serious allergic reaction or rare but dangerous skin condition, and mesna should be stopped right away if they occur.

What happens if I miss a tablet dose or vomit shortly after taking it?

The timing of mesna tablets is important — they need to be in your system at the right moments to protect your bladder. If you vomit within two hours of taking an oral dose, tell your care team right away. They may have you take the dose again or switch you to an IV dose instead. Try not to take the tablet on your own schedule — your care team needs to make that call to keep you protected.

I've heard mesna can interfere with lab tests — what does that mean for me?

Yes, and this is worth knowing before any test. Mesna can cause a false-positive result on urine dipstick tests for ketones — the test may show ketones when there actually aren't any. It can also interfere with a blood test that measures CPK (an enzyme related to muscle), making the result appear falsely low. And it may affect certain urine vitamin C screening tests too. The fix is simple: always tell any lab or healthcare provider that you're taking mesna before any tests are done so they can account for it.

Can I breastfeed while on mesna?

No — you should not breastfeed while taking mesna or for at least one week after your last dose. This recommendation is partly because mesna is used with ifosfamide, which does pass into breast milk and could harm a nursing baby. To be safe, avoid breastfeeding throughout treatment and for the week following your last dose. Talk to your care team about timing if you have questions.

I'm worried about my baby — I've seen something about benzyl alcohol. What should I know?

This is a really important concern if you have a newborn, especially one who was premature or has a low birth weight. Mesna injection contains a preservative called benzyl alcohol, which has caused serious and even fatal reactions in premature and low-birth-weight newborns when given intravenously. Because of this, mesna injection must not be used in those infants. If you are a parent in this situation, make sure your baby's care team knows exactly which medications contain benzyl alcohol. The mesna tablets do not contain benzyl alcohol, which is a key difference between the two forms.

Is mesna available over the counter?

No. Mesna is a prescription medicine: every mesna product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was mesna first available?

The earliest FDA record we hold for mesna is from 1987: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when mesna was first used.

Who makes mesna?

8 companies currently list mesna products in the FDA's NDC Directory, including Baxter Healthcare Company, Bamboo US Bidco LCC, Eugia US LLC. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of mesna?

Mesna is the generic name. Its brand name is Mesnex. Generic versions are listed under the name mesna.

What is the generic name of Mesnex?

The generic name of Mesnex is mesna. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is mesna?

The FDA groups mesna as Cytoprotective Agent.

Is there a generic version of mesna?

Yes. FDA-approved generic versions of mesna are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does mesna come in?

Mesna is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (into a vein): 100 mg/mL. Tablet (by mouth): 400 mg. A listing does not mean every pharmacy stocks every strength.

How much does mesna cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, state Medicaid programs paid an average of $59.33 per 400 mg generic tablet and $71.27 per 400 mg tablet of brand-name Mesnex over the four quarters through Q1 2026 (CMS's State Drug Utilization Data), before the rebates drug makers pay Medicaid. CMS's weekly pharmacy survey (NADAC) has no price for it, and Medicaid's figure is what a program paid, not the price at the counter. No national price was found for mesna injections. The pharmacy prices section of this page lists every strength priced.

Is there a mesna shortage?

No. Mesna is not on the FDA's drug shortage list as of Nov 22, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the mesna prescribing information (package insert)?

The full FDA-approved prescribing information for mesna, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Baxter Healthcare Corporation's, revised Dec 17, 2018, and links to it on DailyMed.

Is mesna gluten free?

No mesna label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 12 mesna products from 8 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's mesna by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See mesna inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Mesna

Skip the scrolling. Ask in your own words and get an answer from Mesna’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Mesna’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Mesna on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Mesna Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Mesna Forms and Strengths (How It Comes)

Mesna comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Mesna inactive ingredients by manufacturer.

Injection

Into a vein
Brands Mesnex (1988)
How this form is used
What it may be used for
  • Mesna injection is used intravenously to reduce the risk of ifosfamide-induced hemorrhagic cystitis (bladder bleeding)
  • Mesnex injection is used intravenously as a cytoprotective agent given alongside ifosfamide chemotherapy
  • Mesna injection can be used as the sole route (three IV bolus doses per ifosfamide cycle) or as the first dose in a combined IV-then-oral regimen
Important instructions
  • Mesna injection is given as intravenous bolus (rapid) injections timed around each ifosfamide dose — at the time of ifosfamide and again at set intervals afterward
  • Mesnex injection dosing is repeated every day that ifosfamide is administered; if the ifosfamide dose changes, the mesna dose ratio must stay the same
  • Mesna injection contains benzyl alcohol — avoid use in premature neonates and low-birth-weight infants
  • Maintain adequate fluid intake and monitor urine for blood (hematuria) throughout treatment, as directed by your care team
Available strengths 1 strength
10 FDA-listed product records ⓘ

Tablet

By mouth
Brands Mesnex (1988)
How this form is used
What it may be used for
  • Mesna tablets are used orally as part of a combined IV-then-oral regimen to reduce the risk of ifosfamide-induced hemorrhagic cystitis
  • Mesnex tablets are taken after an initial Mesnex injection dose, at timed intervals following ifosfamide administration
Important instructions
  • Mesna tablets are taken orally at specific time points after the initial IV mesna dose — follow your prescriber's exact schedule
  • Food does not affect how well oral mesna works in the urine, so tablets may be taken with or without food
  • If you vomit within two hours of taking a mesna tablet, contact your care team immediately — you may need to repeat the dose or receive IV mesna instead
  • The combined IV-and-oral regimen with Mesnex tablets has not been established as effective for higher ifosfamide doses — your care team will determine the appropriate regimen
Available strengths 1 strength
2 FDA-listed product records ⓘ

Mesna on the U.S. Market: Products, Makers and Brands

How Mesna appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

8 companies list 12 Mesna product records with the FDA, mostly as injection, tablet; the earliest marketing or approval year on record is 1987. The one brand name in the directory today is Mesnex; the rest are generics.

2
Dose forms ⓘ
8
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
12
FDA-listed product records ⓘ
1987
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Baxter Healthcare Company42%
Bamboo US Bidco LCC8%
Eugia US LLC8%
Fresenius Kabi USA, LLC8%
Gland Pharma Limited8%
Hikma Pharmaceuticals USA Inc.8%
Other makers17%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Mesna Is Used (Medicaid Data)

How many Mesna prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

848
Medicaid prescriptions filled (Q1–Q4 2025)
$226,803 paid by Medicaid, before rebates

How commonly is Mesna prescribed? Of the 1,682 medications we measure, Mesna ranks #1,356 by Medicaid prescriptions — more than 19% of them.

Where Mesna ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Mesna product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 100 mg/mL injectable solution is the most-dispensed Mesna product — about 80% of these Medicaid prescriptions.

mesna 100 MG/ML Injectable Solution Most dispensed

678 Medicaid prescriptions (Q1–Q4 2025) 80% of Mesna prescriptions shown $16,265 paid by Medicaid, before rebates ≈ $24 per prescription, before rebates

5 of 23 listed NDCs had Medicaid claims. RxNorm 204870

mesna 400 MG Oral Tablet

170 Medicaid prescriptions (Q1–Q4 2025) 20% of Mesna prescriptions shown $210,538 paid by Medicaid, before rebates ≈ $1,238 per prescription, before rebates

2 of 3 listed NDCs had Medicaid claims. RxNorm 142113

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 7 of the 26 listed Mesna NDCs had Medicaid claims.

Compare Mesna Products

A representative set of FDA-listed product records for Mesna — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Injection
100 mg/mL Intravenous Bamboo US Bidco LCC NDA View NDC →
100 mg/mL Intravenous Baxter Healthcare Company × 4 listings NDA View NDC →
100 mg/mL Intravenous Eugia US LLC ANDA View NDC →
100 mg/mL Intravenous Fresenius Kabi USA, LLC ANDA View NDC →
100 mg/mL Intravenous Gland Pharma Limited ANDA View NDC →
100 mg/mL Intravenous Hikma Pharmaceuticals USA Inc. ANDA View NDC →
100 mg/mL Intravenous Sagent Pharmaceuticals ANDA View NDC →
💊Tablet
400 mg Oral Baxter Healthcare Company NDA View NDC →
400 mg Oral Ingenus Pharmaceuticals, LLC ANDA View NDC →

Showing 12 of 12 products — FDA National Drug Code Directory. See every product, package size and price: browse all 12 Mesna NDCs →

Mesna Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Mesna — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Mesna are febrile neutropenia, pyrexia, neutropenia; about 97% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

8,529
Reports mentioning it
97%
Reported as serious
12
Distinct effects shown
Most reported effects
Febrile Neutropenia
1,316
Pyrexia
713
Neutropenia
587
Anaemia
412
Thrombocytopenia
402
Vomiting
389
Nausea
381
Pancytopenia
373
Sepsis
367
Mucosal Inflammation
349
Age groups
Adult · 817Child · 243Elderly · 224Adolescent · 123Infant · 55Neonate · 25

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Mesna in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Mesna FDA Approval History

How Mesna went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Mesna was first approved by the FDA in 1987 (Brand: IFEX/MESNEX KIT · Baxter Hlthcare); the first generic version was approved in 2001. It remains available in U.S. pharmacies today.

1987
Brand approved
Brand: IFEX/MESNEX KIT · Baxter Hlthcare
2001
First generic approved
Lower-cost ANDA competition begins
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Mesna Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Mesna recalls since July 2021.

✅No Mesna recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Mesna in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
2
Strengths
3
Forms in current FDA listings
2 of 2
In current FDA listings No current FDA listing
Ingredient (IN) Mesna RxCUI 44
  1. Dose form (SCDF) Injectable Solution RxCUI 374524
    In current FDA listings
    Its strength (SCD)
  2. Dose form (SCDF) Oral Tablet RxCUI 372790
    In current FDA listings
    Its 2 strengths (SCD)
    • 400 mg RxCUI 142113
    • 600 mg RxCUI 142114

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Medicaid Pays for Mesna

CMS’s weekly pharmacy survey (NADAC) has no price for Mesna, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.

No price was found for Mesna injections, so the prices below are for the tablets only.

FormStrengthVersion What Medicaid paid
Tablet · Oral 400 mg Generic $59.33 per tablet NDC details & Medicaid use
Tablet · Oral 400 mg Mesnex (brand) $71.27 per tablet NDC details & Medicaid use
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.

Mesna Brand Names

Mesna has one brand name on record: Mesnex. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Mesnex 1988

Who Makes Mesna: Manufacturers and Labelers

8 companies list Mesna products with the FDA. By number of product records, the largest are Baxter Healthcare Company, Bamboo US Bidco LCC, Eugia US LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Baxter Healthcare Company 5 Bamboo US Bidco LCC 1 Eugia US LLC 1 Fresenius Kabi USA, LLC 1 Gland Pharma Limited 1 Hikma Pharmaceuticals USA Inc. 1 Ingenus Pharmaceuticals, LLC 1 Sagent Pharmaceuticals 1

Sources for This Mesna Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Dec 17, 2018, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Mesna.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 10 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
10
Finished products in the current FDA directory
12
Companies listing them (makers, repackagers, distributors)
8
FDA labeler codes behind them ⓘ
10
Linked representative label ⓘ
Baxter Healthcare Corporation
Linked label effective
Dec 17, 2018
Composite sections available
22
Linked SPL Set ID
fe1683ef-0569-411e-8188-0499884632ad
Linked SPL Document ID
351aee07-c5c9-46b3-9d0e-c3859796abac
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Baxter Healthcare Corporation is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →